These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1127123)

  • 1. Crosslink in bone collagen in Paget's disease.
    Misra DP
    J Clin Pathol; 1975 Apr; 28(4):305-8. PubMed ID: 1127123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin.
    Lavender JP; Evans IM; Arnot R; Bowring S; Doyle FH; Joplin GF; MacIntyre I
    Br J Radiol; 1977 Apr; 50(592):243-50. PubMed ID: 870130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteolytic Paget's bone disease in a young man. Rapid healing with human calcitonin therapy.
    Whyte MP; Daniels EH; Murphy WA
    Am J Med; 1985 Feb; 78(2):326-32. PubMed ID: 3970056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D in Paget's disease of bone.
    Foldes J; Shamir S; Kidroni G; Menczel J
    Clin Orthop Relat Res; 1989 Jun; (243):275-9. PubMed ID: 2498022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
    Toh SH; Claunch BC; Brown PH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):405-9. PubMed ID: 6822644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paget's disease of bone.
    Krane SM
    Clin Orthop Relat Res; 1977; (127):24-36. PubMed ID: 410574
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
    J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
    Nunziata V; Giannattasio R; di Giovanni G; Lettera AM; Nunziata CA
    Clin Orthop Relat Res; 1993 Aug; (293):366-71. PubMed ID: 8339504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
    Condon JR; Surtees J; Robinson V
    Postgrad Med J; 1981 Feb; 57(664):84-8. PubMed ID: 6455656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New method of measuring total and regional bone fixation of calcium in patients with Paget's disease treated with salmon calcitonin].
    Bergmann P; Schoutens A; Corvilain J
    Strahlentherapie Sonderb; 1975; 74():301-8. PubMed ID: 1239103
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical feature and calcitonin therapy on Paget's disease of bone (author's transl)].
    Dokoh S; Morita R; Yamamoto I; Fukunaga M; Hamanaka D; Torizuka K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Aug; 53(8):937-47. PubMed ID: 574527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcitonin treatment on deafness due to Paget's disease of bone.
    Solomon LR; Evanson JM; Canty DP; Gill NW
    Br Med J; 1977 Aug; 2(6085):485-7. PubMed ID: 890362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paget's disease of the bone.
    Hamdy RC
    Clin Geriatr Med; 1994 Nov; 10(4):719-35. PubMed ID: 7850699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and metabolic investigations in Paget's disease of bone, assessment of human synthetic calcitonin therapy.
    Reiner M; Woodhouse NJ; Kalu DN; Foster GV; Galante L; Joplin GF; MacIntyre I
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:136. PubMed ID: 5288785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.